Is Hepion Pharmaceuticals, Inc. (HEPA) a Buy, Sell, or Hold?
OTC : HEPA
Hepion Pharmaceuticals, Inc. — Insider Trades
$0.0535 USD
$0.01 (17.58%)
- Volume
- 71.64K
- Average Volume
- 28.24K
- Market Capitalization
- $622.94K
- P/E Ratio
- -0.21
- Dividend Yield
- 0.00%
- Price Target
- $70.00
- Year High
- $0.11
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.68
Insider Activity Summary (Last 12 Months)
Insiders Buying
13
Insiders Selling
2
Amount of Insider Selling
$120K
HEPA Insider Buying/Selling by Quarter
HEPA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Stetz Gary S. II | director: | 2026-07-01 | 0 | 2026-07-10 | |
| Fisher Danina | director: | 2026-07-01 | 0 | 2026-07-08 | |
| LoPriore Chase | director | 2026-03-16 | 0 | 2026-05-26 | |
| Purcell Michael J. | director | 2026-04-21 | P-Purchase | 0.04 | 2026-04-27 |
| LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | 2026-04-21 | P-Purchase | 0.04 | 2026-04-27 |
| LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | 2026-04-21 | P-Purchase | 0.04 | 2026-04-27 |
| Appajosyula Sireesh | director | 2026-04-21 | P-Purchase | 0.04 | 2026-04-27 |
| Stetz Gary S. | director, officer: Interim CEO | 2026-04-21 | P-Purchase | 0.04 | 2026-04-27 |
| Stetz Gary S. | director, officer: Chief Executive Officer | 2026-03-16 | 0 | 2026-03-18 | |
| LoPriore Vincent S | director, officer: Executive Chairman | 2026-03-16 | 0 | 2026-03-18 | |
| Appajosyula Sireesh | director: | 2026-03-16 | 0 | 2026-03-18 | |
| Purcell Michael J. | director | 2024-03-06 | A-Award | 0 | 2024-03-07 |
| Purcell Michael J. | director: | 2024-03-05 | 0 | 2024-03-06 | |
| Block Timothy M. | director | 2024-02-19 | A-Award | 2.56 | 2024-02-21 |
| JACOB GARY S | director | 2024-02-19 | A-Award | 2.56 | 2024-02-21 |
| Lbiati Kaouthar | director | 2024-02-19 | A-Award | 2.56 | 2024-02-21 |
| BRANCACCIO JOHN P | director, officer: Chairman | 2024-02-19 | A-Award | 2.56 | 2024-02-21 |
| Wijngaard Peter | director | 2023-11-27 | P-Purchase | 3.05 | 2023-11-28 |
| Wijngaard Peter | director | 2023-11-24 | P-Purchase | 3.09 | 2023-11-28 |
| Wijngaard Peter | director | 2023-09-19 | P-Purchase | 5.64 | 2023-09-20 |
| Wijngaard Peter | director | 2023-09-15 | P-Purchase | 5.37 | 2023-09-20 |
| Wijngaard Peter | director | 2023-09-15 | P-Purchase | 5.45 | 2023-09-20 |
| Wijngaard Peter | director | 2023-09-15 | P-Purchase | 5.82 | 2023-09-20 |
| Foster Robert T | director, officer: CEO and Director | 2023-09-18 | P-Purchase | 5.6 | 2023-09-19 |
| Foster Robert T | director, officer: CEO,CSO and Director | 2023-09-15 | P-Purchase | 5.4 | 2023-09-18 |
| Lbiati Kaouthar | director | 2022-06-27 | 0.69 | 2022-07-20 | |
| Reddi Anand | director | 2022-06-27 | 0.69 | 2022-07-05 | |
| Lippa Arnold | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| Wijngaard Peter | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| JACOB GARY S | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| Foster Robert T | director, officer: CEO, CSO and Director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| Cavan John T | officer: Chief Financial Officer | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| BRANCACCIO JOHN P | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| Block Timothy M. | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| ADAMS THOMAS PHD | director | 2021-05-18 | A-Award | 1.7 | 2021-05-20 |
| Wijngaard Peter | director | 2021-02-16 | P-Purchase | 2.2 | 2021-02-18 |
| Foster Robert T | director, officer: CEO and Director | 2021-02-18 | P-Purchase | 2 | 2021-02-18 |
| Cavan John T | officer: Chief Financial Officer | 2021-02-18 | P-Purchase | 2 | 2021-02-18 |
| Wijngaard Peter | director | 2020-12-18 | P-Purchase | 1.91 | 2020-12-21 |
| Foster Robert T | director, officer: CEO and Director | 2020-12-08 | P-Purchase | 1.5767 | 2020-12-08 |
| BRANCACCIO JOHN P | director | 2020-12-02 | P-Purchase | 1.53 | 2020-12-02 |
| JACOB GARY S | director | 2020-12-01 | P-Purchase | 1.66 | 2020-12-01 |
| Cavan John T | officer: Chief Financial Officer | 2020-11-25 | P-Purchase | 1.62 | 2020-11-30 |
| Foster Robert T | director, officer: CEO,CSO and Director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| Lippa Arnold | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| Block Timothy M. | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| ADAMS THOMAS PHD | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| BRANCACCIO JOHN P | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| JACOB GARY S | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| Cavan John T | officer: Chief Financial Officer | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| Wijngaard Peter | director | 2020-08-19 | A-Award | 3.72 | 2020-08-21 |
| Wijngaard Peter | director | 2020-06-25 | A-Award | 2.73 | 2020-06-25 |
| Wijngaard Peter | director: | 2020-06-10 | 0 | 2020-06-25 | |
| ADAMS THOMAS PHD | director | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| Block Timothy M. | director | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| Lippa Arnold | director | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| BRANCACCIO JOHN P | director | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| Foster Robert T | director, officer: CEO and CSO | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| JACOB GARY S | director | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| Cavan John T | officer: Chief Financial Officer | 2020-04-03 | A-Award | 1.63 | 2020-04-07 |
| Cavan John T | officer: Chief Financial Officer | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| JACOB GARY S | director | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| BRANCACCIO JOHN P | director | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| Block Timothy M. | director | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| ADAMS THOMAS PHD | director | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| Foster Robert T | director, officer: CEO and CSO | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| Lippa Arnold | director | 2019-07-24 | A-Award | 3.24 | 2019-07-25 |
| Garlikov Donald E | 10 percent owner | 2019-03-15 | 0 | 2019-04-02 | |
| Garlikov Donald E | 10 percent owner | 2016-04-04 | 13.6 | 2019-04-02 | |
| Garlikov Donald E | 10 percent owner | 2017-04-28 | 10 | 2019-04-02 | |
| Garlikov Donald E | 10 percent owner | 2015-10-13 | 34 | 2019-04-02 | |
| JACOB GARY S | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| JACOB GARY S | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| Cavan John T | officer: CFO | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| Cavan John T | officer: CFO | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| Lippa Arnold | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| Lippa Arnold | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| BRANCACCIO JOHN P | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| BRANCACCIO JOHN P | director | 2018-07-03 | P-Purchase | 1.55 | 2018-07-03 |
| Cavan John T | officer: CFO | 2018-01-03 | A-Award | 0 | 2018-01-05 |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2018-01-03 | A-Award | 0 | 2018-01-05 |
| Foster Robert T | officer: Chief Scientific Officer | 2018-01-03 | A-Award | 0 | 2018-01-05 |
| Cavan John T | officer: Chief Financial Officer | 2017-07-20 | A-Award | 0.58 | 2017-07-21 |
| Cavan John T | officer: CFO | 2017-07-06 | A-Award | 0 | 2017-07-07 |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2017-07-06 | A-Award | 0 | 2017-07-07 |
| Sullivan-Bolyai John Z | officer: Chief Medical Officer | 2017-07-06 | A-Award | 0 | 2017-07-07 |
| Foster Robert T | officer: Chief Scientific Officer | 2017-07-06 | A-Award | 0 | 2017-07-07 |
| Cavan John T | officer: CFO | 2017-06-20 | P-Purchase | 0.65 | 2017-06-22 |
| HOWSON TAMAR D | director | 2017-04-10 | A-Award | 1.6 | 2017-04-11 |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2017-03-06 | A-Award | 1.48 | 2017-03-07 |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2017-03-03 | A-Award | 1.43 | 2017-03-07 |
| HOWSON TAMAR D | director | 2016-12-14 | 2.01 | 2016-12-15 | |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2016-10-27 | M-Exempt | 1.5 | 2016-10-31 |
| SAPIRSTEIN JAMES | director, officer: Chief Executive Officer | 2016-10-27 | M-Exempt | 1.5 | 2016-10-31 |
| ADAMS THOMAS PHD | director | 2016-09-20 | 1.12 | 2016-09-21 | |
| Sullivan-Bolyai John Z | officer: Chief Medical Officer | 2016-08-26 | A-Award | 1.1 | 2016-08-29 |
| Cavan John T | officer: Chief Financial Officer | 2016-08-26 | A-Award | 1.1 | 2016-08-29 |
| CERRONE GABRIEL | 10 percent owner | 2016-08-17 | 0 | 2016-08-17 | |
| CERRONE GABRIEL | 10 percent owner | 2016-08-17 | 0 | 2016-08-17 | |
| CERRONE GABRIEL | 10 percent owner | 2016-08-17 | 0.94 | 2016-08-17 |